Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asacol Non-inferiority Study in Active Ulcerative Colitis
NCT01257386Phase 3Completed
- Sponsor
- Tillotts Pharma AG
- Start
- Nov 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Tillotts Pharma AG. Started Nov 2010; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01257386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257386.